n(4)-hydroxycytidine has been researched along with 2-amino-n(6)-hydroxyadenine in 1 studies
Studies (n(4)-hydroxycytidine) | Trials (n(4)-hydroxycytidine) | Recent Studies (post-2010) (n(4)-hydroxycytidine) | Studies (2-amino-n(6)-hydroxyadenine) | Trials (2-amino-n(6)-hydroxyadenine) | Recent Studies (post-2010) (2-amino-n(6)-hydroxyadenine) |
---|---|---|---|---|---|
42 | 1 | 32 | 26 | 0 | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bittner, F; Clement, B; Garbe-Schönberg, D; Havemeyer, A; Krischkowski, C; Krompholz, N; Mendel, RR; Reichmann, D | 1 |
1 other study(ies) available for n(4)-hydroxycytidine and 2-amino-n(6)-hydroxyadenine
Article | Year |
---|---|
The mitochondrial Amidoxime Reducing Component (mARC) is involved in detoxification of N-hydroxylated base analogues.
Topics: Adenine; Biocatalysis; Cytidine; Cytosine; Humans; Mitochondrial Proteins; Oxidation-Reduction; Oxidoreductases; Recombinant Proteins | 2012 |